- ￥290 - 1990
- Solarbio
- 北京
- ID2020
- 2025年07月23日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
Powder:-20℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 保质期：
Powder:-20℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 英文名：
Disodium (R)-2-Hydroxyglutarate
- 库存：
现询
- 供应商：
北京索莱宝科技有限公司
- CAS号：
103404-90-6
- 规格：
100mg/50mg/25mg/5mg/10mg
| 规格： | 100mg | 产品价格： | ￥1990.0 |
|---|---|---|---|
| 规格： | 50mg | 产品价格： | ￥1190.0 |
| 规格： | 25mg | 产品价格： | ￥690.0 |
| 规格： | 5mg | 产品价格： | ￥290.0 |
| 规格： | 10mg | 产品价格： | ￥470.0 |
| 基本信息 | |
| CAS | No.103404-90-6 |
| 中文名称 | 2-羟基-D-谷氨酸二钠盐 |
| 英文名称 | Disodium (R)-2-Hydroxyglutarate |
| 别名 | (R)-2-羟基戊二酸二钠盐;(R)-2-羟基戊二酸 |
| 分子式 | C5H6O5Na2 |
| 分子量 | 192.08 |
| 溶解性 | Soluble in Water ≥2mg/mL |
| 纯度 | ≥98% |
| 外观(性状) | White to yellow Solid |
| 储存条件 | Powder:-20℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| MDL | MFCD00069573 |
| SMILES | O=C([O-])[C@H](O)CCC([O-])=O.[Na+].[Na+] |
| InChIKey | DZHFTEDSQFPDPP-HWYNEVGZSA-L |
| InChI | InChI=1S/C5H8O5.2Na/c6-3(5(9)10)1-2-4(7)8;;/h3,6H,1-2H2,(H,7,8)(H,9,10);;/q;2*+1/p-2/t3-;;/m1../s1 |
| PubChem CID | 51051608 |
| 靶点 | α-ketoglutarate-dependent dioxygenases |
| 通路 | Metabolic Enzyme&Protease |
| 背景说明 | Disodium (R)-2-Hydroxyglutarate是一种稍弱的竞争性 α-酮戊二酸 (α-KG) 依赖性双加氧酶抑制剂。 |
| 生物活性 | D-α-Hydroxyglutaric acid disodium (Disodium (R)-2-hydroxyglutarate) is the principal metabolite accumulating in neurometabolic disease D-2-hydroxyglutaric aciduria. D-α-Hydroxyglutaric acid disodium is a weak competitive antagonist of α-ketoglutarate (α-KG) and inhibits multiple α-KG-dependent dioxygenases with a Ki of 10.87 mM. D-α-Hydroxyglutaric acid disodium increases reactive oxygen species (ROS) production. D-α-Hydroxyglutaric acid disodium binds and inhibits ATP synthase and inhibits mTOR signaling[1-5]. |
| IC50 | Ki: 10.87 mM (α-KG-dependent dioxygenases)[1] |
| In Vitro | D-α-Hydroxyglutaric acid is a weak inhibitor of TET hydroxylases. In the presence of 0.1 mM of α-KG， addition of 10 mM D-α-Hydroxyglutaric acid results in a partial (33%) inhibition of TET2 and addition of 50 mM D-α-Hydroxyglutaric acid results in more inhibition (83%) of TET2. D-α-Hydroxyglutaric acid exhibits a less pronounced inhibitory effect toward TET1[1]. |
| 细胞实验 | D-α-Hydroxyglutaric acid has also been proposed as an endogenous excitotoxic organic acid because it significantly decreased cell viability in neuronal cultures from chick embryo telencephalons and from neonatal rat hippocampus through stimulation of specific NMDA glutamate receptors[5]. |
| 细胞实验 | U87 cells， HCT 116 IDH1(R132H/+) cells， and HEK 293 cells are seeded in 12-well plates and after overnight incubation are treated with indicated concentrations of each compound (e.g.， 400 and 800 μM D-α-Hydroxyglutaric acid). After harvesting， cells are stained with Acridine Orange (AO) and DAPI. Cell number and viability are measured based on AO and DAPI fluorescence measured by NC3000[2]. |
| 动物实验 | D-α-Hydroxyglutaric acid (0.01-1 mM) significantly increases chemiluminescence and thiobarbituric acid-reactive substances (TBA-RS) and decreased total antioxidant reactivity (TAR) values in the cortical supernatants in 30-day-old-rats[5]. |
| 数据来源文献 | [1]. Xu W， et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011 Jan 18;19(1):17-30. [2]. Fu X， et al. 2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling. Cell Metab. 2015 Sep 1;22(3):508-15. [3]. Martijn Kranendijk， et al. Progress in understanding 2-hydroxyglutaric acidurias. J Inherit Metab Dis. 2012 Jul;35(4):571-87. [4]. Martin B?ttcher， et al. D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization. Oncoimmunology. 2018 Mar 26;7(7):e1445454. [5]. Alexandra Latini ， et al. D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats. Eur J Neurosci. 2003 May;17(10):2017-22. |
| 单位 | 瓶 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Nat Methods 2020 年度技术方法：空间转录组到底是什么，怎么做，怎么用
作用事件提供更全面的观点。 从空间大宇宙，到人身小宇宙，科学就是这么迷人！图片来源：Nature Methods本周推荐：三句话读懂一篇 CNS，首次揭示从鱼进化到人的演变机制，运动能帮助人体对抗慢性炎症...两院院士评选 2020 年中国、世界十大科技进展揭晓中科院高福院士课题组 2020 年研究成果盘点Cell Metab：延寿新点子，多吃脂肪活的久？哈尔滨医科大学孙长颢 / 李颖 / 牛玉存报道等热量的中等高脂饮食可延长寿命盘点 2020 年中国学者的十大免疫学研究成果，有的已经被写进高考
盘点 2020 年中国学者的十大免疫学研究成果，有的已经被写进高考题？！
尽管新冠疫情给大家的研究工作带来了诸多不便，但回顾 2020 年，国内免疫学界还是给大家带来了不少令人印象深刻的工作 —— 肿瘤免疫的继续推进、神经免疫的开创发现、免疫在新冠研究中的大放异彩……今天丁香学术和大家一起来细数这些精彩研究～Let's go!1. CAR-T 治疗为何会诱导炎症因子风暴的发生？嵌合抗原受体 T 细胞（CAR-T）疗法为人类战胜癌症带来胜利曙光。然而，CAR-T 治疗却会带来严重的副作用 —— 炎症因子风暴（Cytokine release syndrome，CRS
Nature 重磅：新发脑胶质瘤疫苗初见成效，瞄准肿瘤「阿喀琉斯之踵」
. 2020 May;122(11):1580-1589. doi: 10.1038/s41416-020-0814-x.[2] Michael Platten et al. A vaccine targeting mutant IDH1 in newly diagnosed glioma. Nature, 2021, https://www.nature.com/articles/s41586-021-03363-z.[3] Tran E, et al. T-Cell Transfer Therapy
技术资料暂无技术资料 索取技术资料
